Trelegy Ellipta is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting β2-agonist.
The recommended and maximum dose is one inhalation of Trelegy Ellipta 92/55/22 micrograms once daily, at the same time each day. If a dose is missed the next dose should be taken at the usual time the next day.
Trelegy Ellipta is not indicated for use in those patients under the age of 18 years.
Trelegy Ellipta should not be used in patients with asthma.